2024-28433. Determination That Bentyl Preservative Free (Dicyclomine Hydrochloride) Injection, 10 Milligrams/Milliliters, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Table 1—Drug Products Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Application No. Drug name Active ingredient(s) Dosage form/route Strength(s) Applicant NDA 008370 BENTYL PRESERVATIVE FREE Dicyclomine Hydrochloride Injectable; Injection 10 Milligrams (mg)/Milliliters (mL) AbbVie. NDA 012104 KENALOG Triamcinolone Acetonide Spray; Topical 0.147 mg/Gram (g) Sun Pharmaceutical Industries Limited. NDA 017806 THALLOUS CHLORIDE TL 201 Thallous Chloride TL-201 Injectable; Intravenous 1 Millicurie (mCi)/mL; 2 mCi/mL Lantheus. NDA 017823 HALOG Halcinonide Solution; Topical 0.10% Sun Pharmaceutical Industries Limited. NDA 018849 LIDEX Fluocinonide Solution; Topical 0.05% Alvogen. NDA 020551 NIMBEX Cisatracurium Besylate Injectable; Injection Equivalent to (EQ) 2 mg Base/mL AbbVie. NDA 020551 NIMBEX PRESERVATIVE FREE Cisatracurium Besylate Injectable; Injection EQ 2 mg Base/mL; EQ 10 mg Base/mL AbbVie. ( print page 96655) NDA 020837 XOPENEX Levalbuterol Hydrochloride Solution; Inhalation EQ 0.0103% Base; EQ 0.021% Base; EQ 0.042% Base; EQ 0.25% Base Hikma. NDA 020857 COMBIVIR Lamivudine; Zidovudine Tablet; Oral 150 mg; 300 mg Viiv Health Care. NDA 020977 ZIAGEN Abacavir Sulfate Tablet; Oral EQ 300 mg Base Viiv Health Care. NDA 021205 TRIZIVIR Abacavir Sulfate, Lamivudine, Zidovudine Tablet; Oral EQ 300 mg Base, 150 mg, 300 mg Viiv Health Care. NDA 021223 ZOMETA Zoledronic Acid Injectable; Intravenous EQ 4 mg Base/100 mL; EQ 4 mg Base/5 mL Novartis. NDA 021548 LEXIVA Fosamprenavir Calcium Tablet; Oral EQ 700 mg Base Viiv Health Care. NDA 021695 ANTARA (MICRONIZED) Fenofibrate Capsule; Oral 90 mg Lupin. NDA 021738 EXTINA Ketoconazole Aerosol, Foam; Topical 2% Mylan. NDA 021861 PATANASE Olopatadine Hydrochloride Spray, Metered; Nasal 0.665 mg/Spray Novartis. NDA 022128 SELZENTRY Maraviroc Tablet; Oral 25 mg; 75 mg Viiv Health Care. NDA 022350 ONGLYZA Saxagliptin Hydrochloride Tablet; Oral EQ 2.5 mg Base; EQ 5 mg Base AstraZeneca AB. NDA 050440 KEFLET Cephalexin Tablet; Oral EQ 250 mg Base; EQ 500 mg Base Eli Lilly and Company. NDA 050558 ZINACEF Cefuroxime Sodium Injectable; Intramuscular, Intravenous EQ 750 mg Base/Vial; EQ 1.5 g Base/Vial; EQ 7.5 g Base/Vial PAI Pharma. NDA 050567 POLYTRIM Polymyxin B Sulfate, Trimethoprim Sulfate Solution/Drops; Ophthalmic 10,000 Units/mL, EQ 1 mg Base/mL Allergan. NDA 050588 CEFOTAN Cefotetan Disodium Injectable; Injection EQ 10 g Base/Vial PAI Pharma. NDA 050795 DORYX Doxycycline Hyclate Tablet, Delayed Release; Oral EQ 75 mg Base; EQ 150 mg Base Mayne Pharma. NDA 200678 KOMBIGLYZE XR Metformin Hydrochloride, Saxagliptin Hydrochloride Tablet, Extended Release; Oral 500 mg, EQ 5 mg Base; 1 g, EQ 5 mg Base; 1 g, EQ 2.5 mg Base AstraZeneca AB. NDA 201194 OXYCODONE HYDROCHLORIDE Oxycodone Hydrochloride Solution; Oral 5 mg/5 mL VistaPharm, LLC. NDA 204427 KERYDIN Tavaborole Solution; Topical 5% Anacor Pharmaceuticals, Inc. NDA 204592 ZORVOLEX Diclofenac Capsule; Oral 35 mg Zyla. NDA 204790 TIVICAY Dolutegravir Sodium Tablet; Oral EQ 10 mg Base; EQ 25 mg Base Viiv Health Care. NDA 215868 MIDAZOLAM IN 0.8% SODIUM CHLORIDE Midazolam Solution; Intravenous 50 mg/50 mL (1 mg/mL) Exela Pharma.
Document Information
- Published:
- 12/05/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2024-28433
- Pages:
- 96654-96655 (2 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-5354
- PDF File:
- 2024-28433.pdf